TNYA Stock Summary and Trading Ideas (Tenaya Therapeutics | NASDAQ:TNYA)

Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.

Tenaya Therapeutics trades on the NASDAQ stock market under the symbol TNYA.

As of February 5, 2026, TNYA stock price declined to $0.75 with 3,105,078 million shares trading.

TNYA has a beta of 2.79, meaning it tends to be more sensitive to market movements. TNYA has a correlation of 0.10 to the broad based SPY ETF.

TNYA has a market cap of $162.38 million. This is considered a Micro Cap stock.

In the last 3 years, TNYA traded as high as $8.09 and as low as $.36.

The top ETF exchange traded funds that TNYA belongs to (by Net Assets): VTI, IBB, VXF, IBBQ, BIB.

TNYA has underperformed the market in the last year with a return of -27.2%, while the SPY ETF gained +13.8%. In the last 3 month period, TNYA fell short of the market, returning -45.7%, while SPY returned +0.6%. However, in the most recent 2 weeks TNYA has outperformed the stock market by returning +4.8%, while SPY returned -1.1%.

TNYA support price is $.79 and resistance is $.90 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TNYA shares will trade within this expected range on the day.